Close Menu

NEW YORK – Siemens Healthineers said Tuesday it has received US Food and Drug Administration clearance for its RapidPoint 500e Blood Gas Analyzer, which is used to monitor critically ill patients, including those with COVID-19, in acute care settings.

The analyzer is now available in the US, as well as in Europe and countries requiring the CE mark where it was launched in August 2019, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.